ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC

BACKGROUND: The nucleoside analog, ARC (NSC 188491) is a recently characterized transcriptional inhibitor that selectively kills cancer cells and has the ability to perturb angiogenesis in vitro. In this study, the mechanism of action of ARC was further investigated by comparing in vitro and in vivo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Stockwin, Luke H, Yu, Sherry X, Stotler, Howard, Hollingshead, Melinda G, Newton, Dianne L
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2009
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651907/
https://ncbi.nlm.nih.gov/pubmed/19232100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-63
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki